(FXR) |
| 0 (0%) 05-29 17:13 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 103.86 |
| Resistance 1: | 88.92 |
| Pivot price: | 85.79 |
| Support 1: | 84.95 |
| Support 2: | 82.50 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 26 May 2026
FXR, Spring Creek MX Park extend partnership - MSN
Fri, 08 May 2026
Larry Curik’s Nitrous-Fed Harley FXR Reborn: The Story Behind the Lone Star Outlaw Pro-Street Build - Hot Bike Magazine
Sat, 14 Mar 2026
Nigakinone enhances FXR expression to synergize with irinotecan in suppressing colorectal cancer cells and xenografts - ScienceDirect.com
Tue, 10 Mar 2026
FXR RELEASES THEIR 2026.5 SPRING COLLECTION - Motocross Action Magazine
Mon, 16 Feb 2026
Bryan Schimke Returns with a 1982 Harley-Davidson FXR – TPJ Style - Hot Bike Magazine
Thu, 05 Feb 2026
Epigenetic regulation and posttranslational modifications of FXR: underlying mechanisms and implications in digestive diseases - Nature
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
